Bronchodilator Agents: all 1,999 studies that test it
Page 20 of 20. Open to participants first (185), then studies with results posted, then the rest; newest registration first within each.
- A Study to Assess the Concentration of Budesonide in Breast Milk From Asthmatic WomenCompletedNCT00228475Phase 4
- Vascular Response to Isoproterenol and β2 Adrenergic Receptor PolymorphismsCompletedNCT00226551Not applicable
- Study In Adults And Adolescents With Seasonal Allergic Rhinitis.CompletedNCT00225823Phase 3
- A Randomized, Double-Blind, Trial Comparing Epinephrine Versus Phenylephrine as a Vasoconstrictor in Regional Anesthesia for Upper Extremity SurgeryCompletedNCT00225043Not applicable
- Long Term Safety Of GW685698X Via Nasal BiopsyCompletedNCT00224523Phase 3
- Treatment of Orthostatic Hypotension in Autonomic FailureCompletedNCT00223691Phase 1
- Study in Patients With COPDCompletedNCT00215449Phase 3
- A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPDCompletedNCT00215436Phase 3
- Study in Patients With COPDCompletedNCT00215423Phase 2
- Study in Patients With AsthmaCompletedNCT00215410Phase 2
- Study in Patients With AsthmaCompletedNCT00215397Phase 2
- Study in Patients With COPDCompletedNCT00215384Phase 2
- Study in Patients With AsthmaCompletedNCT00215371Phase 2
- Study in Patients With AsthmaCompletedNCT00215358Phase 2
- A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPDCompletedNCT00206167Phase 3
- A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD PatientsCompletedNCT00206154Phase 3
- Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00202189Phase 4
- Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00202176Phase 4
- Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of StrokeCompletedNCT00202020Phase 3
- Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)CompletedNCT00197262Phase 3
- Effect of an Inhaled Corticosteroid on Airway Gene Expression in AsthmaCompletedNCT00187499Not applicable
- Nitroglycerin Versus Terbutaline for Intrapartum Fetal ResuscitationCompletedNCT00185887Not applicable
- Treatment of Microscopic ColitisTerminatedNCT00184171Not applicable
- Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways DiseaseTerminatedNCT00180843Not applicable
- Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell TransplantationCompletedNCT00180089Phase 3
- Budesonide for Maintenance Treatment of Collagenous ColitisCompletedNCT00180076Phase 3
- Budesonide Treatment for Lymphocytic ColitisCompletedNCT00180050Phase 3
- The Autonomic Nervous System and ObesityCompletedNCT00179023Phase 1
- Differentiation Induction in Acute Myelogenous LeukemiaCompletedNCT00175812Phase 1/2
- A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide)CompletedNCT00175747Phase 2/3
- Inhaled Steroid Reduces Systemic Inflammation in COPDCompletedNCT00175565Phase 4
- Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.CompletedNCT00169546Phase 4
- Genetic Determinants of the Bronchodilatation Effect of Albuterol ex-VivoStatus unknownNCT00162422Not applicable
- Genetic Determinants of the Response to Salbutamol Among Asthma PatientsStatus unknownNCT00162396Not applicable
- Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress SyndromeTerminatedNCT00159510Phase 1
- Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma MedicationsCompletedNCT00158834Phase 3
- Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD PatientsCompletedNCT00157235Phase 3
- Follow-up at School-age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature InfantsCompletedNCT00152542Phase 3
- ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.CompletedNCT00144911Phase 4
- A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00144326Phase 3
- 12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD)CompletedNCT00144196Phase 4
- Inhaled Nitric Oxide for Pediatric Painful Sickle CrisisTerminatedNCT00142051Phase 2
- Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272)CompletedNCT00139932Phase 4
- NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the NewbornCompletedNCT00139217Not applicable
- Long-Term Treatment of Collagenous Colitis With BudesonideStatus unknownNCT00139165Phase 3
- A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral BudesonideCompletedNCT00135408Phase 2
- Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary DiseaseCompletedNCT00134979Phase 4
- Dopexamine and Norepinephrine Compared With Epinephrine Alone in Septic ShockCompletedNCT00134212Phase 2
- Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)Status unknownNCT00132743Phase 3
- Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell TransplantationCompletedNCT00128739Phase 3
- High Dose Trial in COPDCompletedNCT00128440Phase 2
- Vasopressin and Epinephrine Versus Epinephrine Alone in Cardiac ArrestCompletedNCT00127907Phase 4
- Trial of Terbutaline for the Treatment of Status Asthmaticus in ChildrenCompletedNCT00124995Phase 4
- Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic EsophagitisCompletedNCT00123656Phase 2
- Effects of Epinephrine and Intravenous (I.V.) Needle on Cardiopulmonary Resuscitation (CPR) OutcomeCompletedNCT00121524Phase 2
- Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled TrialStatus unknownNCT00120978Phase 4
- Rosiglitazone Versus Theophylline in Asthmatic SmokersCompletedNCT00119496Phase 2/3
- Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of ActionCompletedNCT00118729Phase 3
- A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or ExerciseCompletedNCT00118690Phase 4
- Nasal Ocular Reflexes Contribute to Eye SymptomsCompletedNCT00117832Not applicable
- A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In PediatricsCompletedNCT00116883Phase 3
- A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and AdultsCompletedNCT00116818Phase 3
- A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD ExacerbationsCompletedNCT00116402Phase 1
- Study In Adults And Adolescents With Seasonal Allergic RhinitisCompletedNCT00115622Phase 3
- Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease ExacerbationsCompletedNCT00115492Phase 4
- Trial of Epinephrine and Albuterol in BronchiolitisStatus unknownNCT00114478Not applicable
- Comparison of Two Bronchodilator Inhalers in Pediatric AsthmaticsCompletedNCT00112411Phase 2
- Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal SprayCompletedNCT00109486Phase 3
- Perennial Allergic Rhinitis Study In Pediatric SubjectsCompletedNCT00108914Phase 3
- Seasonal Allergic Rhinitis In Pediatric SubjectsCompletedNCT00107757Phase 3
- A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).CompletedNCT00103454Phase 3
- Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol XinafoateCompletedNCT00102882Phase 4
- Study Of Asthma In Patients Of African DescentCompletedNCT00102765Phase 4
- An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years OldCompletedNCT00094692Phase 3
- Trial Comparing Daily Atropine Versus Weekend AtropineCompletedNCT00094614Phase 4
- To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPDCompletedNCT00064415Phase 3
- Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung TransplantationTerminatedNCT00060450Phase 3
- Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's PhenomenonCompletedNCT00048776Phase 4
- Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's PhenomenonCompletedNCT00048763Phase 4
- Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric OxideTerminatedNCT00041574Phase 2
- Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in PediatricsTerminatedNCT00041561Phase 3
- Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical VentilationTerminatedNCT00041548Phase 1/2
- Treatment of Multiple Sclerosis With Copaxone and AlbuterolCompletedNCT00039988Not applicable
- Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)CompletedNCT00027391Not applicable
- Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary HypertensionCompletedNCT00023296Phase 1
- Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory FailureTerminatedNCT00016523Phase 3
- Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature InfantsCompletedNCT00006401Phase 3
- Budesonide in Treating Former and Current Smokers With Bronchial DysplasiaCompletedNCT00005880Phase 2
- Inhaled Nitric Oxide Study for Respiratory Failure in NewbornsTerminatedNCT00005776Phase 3
- Early Inhaled Nitric Oxide for Respiratory Failure in NewbornsTerminatedNCT00005773Phase 3
- A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic FibrosisSuspendedNCT00005110Not applicable
- Pilot Study of Budesonide for Patients With Primary Sclerosing CholangitisCompletedNCT00004842Phase 1
- Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular DystrophyCompletedNCT00004685Not applicable
- Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic LeukemiaCompletedNCT00003808Phase 2
- Theophylline in Treating Cancer Patients With Shortness of BreathCompletedNCT00003684Phase 3
- Amblyopia (Lazy Eye) Treatment StudyCompletedNCT00001864Phase 3
- Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell AnemiaCompletedNCT00001716Phase 2
- Lung Health Study (LHS) I and IIICompletedNCT00000568Phase 3
- Occlusion Versus Pharmacologic Therapy for Moderate AmblyopiaCompletedNCT00000170Phase 3